Sign in
4

Changes in Ownership

SAB Biotherapeutics, Inc. Filed Acc 0001493152-21-026394

Options or other derivatives

  • SVP Regulatory Affairs acquired 17,681 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Carillo Carlos N SVP Regulatory Affairs 2021-10-22 Grant or award · Employee Stock Option (right to buy) +17,681 17,681 D: show line 1 in the form
Loading xslF345X03/ownership.xml…